Monday, December 1

Healthcare

McKesson slips as Q2 outlook underwhelms

09/07/20241 Min Read

McKesson outlook slips underwhelms

Previous ArticlePerspective gets FDA fast track status for radiopharmaceutical VMT01

Next Article Abbott launches over-the-counter glucose monitor, Lingo